Quantitative comparison of three- and two-dimensional PET with human brain studies.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Nuclear Medicine

• Publication date

  1998-10-01

• Fields of study

  Medicine, Mathematics

• Identifiers
  PMID 9776275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phantom study evaluating the quantitative aspect of 3D PET imaging of the brain.

  1998cited by this paper
• Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjects.

  1998cited by this paper
• Normalization for 3D PET with a low-scatter planar source and measured geometric factors.

  1998cited by this paper
• Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data

  1996cited by this paper
• Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

  1996cited by this paper
• Evaluation of the ICS and DEW scatter correction methods for low statistical content scans in 3D PET

  1996cited by this paper
• Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.

  1995cited by this paper
• Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific

  1995cited by this paper
• A convolution-subtraction scatter correction method for 3D PET.

  1994cited by this paper
• Physical performance of a positron tomograph for brain imaging with retractable septa.

  1992cited by this paper
• Measuring PET scanner sensitivity: relating countrates to image signal-to-noise ratios using noise equivalents counts

  1990cited by this paper
• Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects

  1990cited by this paper
• Analytic 3D image reconstruction using all detected events

  1989cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper

• Multi-tracer PET correlation analysis reveals disease-specific patterns in Parkinson’s disease and asymptomatic LRRK2 pathogenic variant carriers compared to healthy controls

  2024cites this paper
• Quantitative hemodynamic PET imaging using image-derived arterial input function and a PET/MR hybrid scanner

  2017cites this paper
• Brain activity associated with chronic cancer pain.

  2010cites this paper
• Prospective Evaluation Brain Activity Associated with Chronic Cancer Pain

  2010cites this paper
• Dopamine turnover increases in asymptomatic LRRK2 mutations carriers

  2010cites this paper
• Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function

  2010cites this paper
• Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease

  2008cites this paper
• Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study

  2007cites this paper
• Quantification of Cerebral Blood Flow and Oxygen Metabolism with 3-Dimensional PET and 15O: Validation by Comparison with 2-Dimensional PET

  2007cites this paper
• Issues in quantification of cardiac PET studies

  2007influential citation
• Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications.

  2006cites this paper
• Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: Positron emission tomographic studies

  2006cites this paper
• Dynamic imaging on the high resolution research tomograph (HRRT): non-human primate studies

  2005cites this paper
• PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.

  2005cites this paper
• Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET.

  2004cites this paper
• Role of the level of expression of striatal dopamine transporter relative to striatal dopaminergic terminals in the pathogenesis of levodopa induced motor fluctuations in Parkinson’s disease

  2004cites this paper
• Changes of Dopamine Turnover in the Progression of Parkinson's Disease as Measured by Positron Emission Tomography: Their Relation to Disease-Compensatory Mechanisms

  2004cites this paper
• Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.

  2004cites this paper
• Effect of Dopamine Loss and the Metabolite 3-O-Methyl-[18F]Fluoro-dopa on the Relation between the 18F-Fluorodopa Tissue Input Uptake Rate Constant Kocc and the [18F]Fluorodopa Plasma Input Uptake Rate Constant Ki

  2003cites this paper
• Effects of attenuation correction and reconstruction method on PET activation studies

  2003cites this paper
• [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease.

  2003cites this paper
• DTBZ-PET correlates of levodopa responses in asymmetric Parkinson ' s disease

  2003cites this paper
• Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change

  2002cites this paper
• BIOLOGICAL INTERPRETATION OF QUANTITATIVE PET BRAIN DATA

  2002cites this paper
• Increase in Dopamine Turnover Occurs Early in Parkinson's Disease: Evidence from a New Modeling Approach to PET 18F-Fluorodopa Data

  2002influential citation
• [18F]‐Dopa positron emission tomography imaging in early‐stage, non‐parkin juvenile parkinsonism

  2002cites this paper
• Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET

  2001cites this paper
• Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover

  2001cites this paper
• Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.

  2001cites this paper
• Apomorphine-Induced Changes in Synaptic Dopamine Levels: Positron Emission Tomography Evidence for Presynaptic Inhibition

  2001cites this paper
• Sensitive measurement of positron emitters eluted from HPLC.

  2001cites this paper
• Comparison of 2D and 3D PET for cerebral FDG in human subjects

  2000cites this paper
• In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

  2000cites this paper
• Comparison of FORE, OSEM and SAGE algorithms to 3DRP in 3D PET using phantom and human subject data

  1998cites this paper